Keyphrases
Positron Emission Tomography
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
High-dose Therapy
100%
Aggressive Lymphoma
100%
Risk-adapted
100%
Positron Emission
66%
Tomographic Scan
66%
Clinical Outcomes
33%
Hematological Malignancies
33%
Early Implementation
33%
Chemotherapy
33%
Clinical High Risk
33%
Lymphoma
33%
Poor Clinical Outcomes
33%
Early Identification
33%
Few-cycle
33%
Solid Malignancies
33%
Prognostic Score
33%
Intensive Care Medicine
33%
Prognostic Tool
33%
Risk Assessment
33%
Metabolic Imaging
33%
Fluorine-18-fluorodeoxyglucose Positron Emission Tomography
33%
Response Assessment
33%
Relapse Risk
33%
Risk-based Approach
33%
Individualized Risk
33%
Implications for Management
33%
Medicine and Dentistry
Positron Emission Tomography
100%
Drug Megadose
100%
Aggressive Lymphoma
100%
Polyethylene Terephthalate
100%
Hematologic Malignancy
16%
Intensive Care
16%
Fluorodeoxyglucose
16%
Fluorine-18
16%